| Identification | Back Directory | [Name]
Mal-VC-PAB-DM1 | [CAS]
1464051-44-2 | [Synonyms]
Mal-VC-PAB-DM1
Maytansine, N2'-deacetyl-N2'-[[[4-[[N-[6-(1,5-dihydro-1,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]- | [Molecular Formula]
C61H82ClN9O17 | [MDL Number]
MFCD32263388 | [MOL File]
1464051-44-2.mol | [Molecular Weight]
1248.81 |
| Chemical Properties | Back Directory | [Boiling point ]
1343.1±65.0 °C(Predicted) | [density ]
1.36±0.1 g/cm3(Predicted) | [solubility ]
DMSO : 75 mg/mL (60.06 mM; Need ultrasonic) | [form ]
Solid | [pka]
9.82±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Mal-VC-PAB-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker Mal-VC-PAB [1]. | [IC 50]
Maytansinoids | [References]
[1] Brian Lannutti, et al. Ror1 antibody immunoconjugates. WO2018237335A1. |
|
|